Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
LOS ANGELES--(BUSINESS WIRE)--The Angeles Clinic and Research Institute presented groundbreaking new data on “Clinical Activity, Safety and Biomarkers of MPDL3280A, an Engineered PD-L1 Antibody in Patients with Metastatic Melanoma” at the American Society of Clinical Oncology (ASCO) 2013 Annual Meeting convening in Chicago this week (Abstract #9010). The oral presentation was made by Omid Hamid, M.D., Director of the Melanoma Program and Head of Clinical Research at The Angeles Clinic and Research Institute.
Help employers find you! Check out all the jobs and post your resume.
